CLDN34
gene geneOn this page
Summary
CLDN34 (claudin 34, HGNC:51259) is a protein-coding gene on chromosome Xp22.2, encoding Claudin-34 (H7C241). Plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity.
Predicted to enable structural molecule activity. Predicted to be involved in bicellular tight junction assembly and cell adhesion. Predicted to be active in bicellular tight junction and plasma membrane.
Source: NCBI Gene 100288814 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 28 total
- MANE Select transcript:
NM_001195081
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:51259 |
| Approved symbol | CLDN34 |
| Name | claudin 34 |
| Location | Xp22.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000234469 |
| Ensembl biotype | protein_coding |
| Entrez | 100288814 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000445307, ENST00000850986
RefSeq mRNA: 1 — MANE Select: NM_001195081
NM_001195081
CCDS: CCDS75951
Canonical transcript exons
ENST00000445307 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00004283157 | 9967358 | 9968352 |
Expression profiles
Bgee: expression breadth broad, 42 present calls, max score 50.99.
Top tissues by expression
84 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 50.99 | gold quality |
| testis | UBERON:0000473 | 50.85 | gold quality |
| right testis | UBERON:0004534 | 50.44 | gold quality |
| right lobe of liver | UBERON:0001114 | 44.64 | silver quality |
| islet of Langerhans | UBERON:0000006 | 43.93 | gold quality |
| liver | UBERON:0002107 | 42.85 | silver quality |
| colonic epithelium | UBERON:0000397 | 42.81 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 41.82 | silver quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 41.80 | gold quality |
| skin of abdomen | UBERON:0001416 | 40.57 | silver quality |
| esophagus mucosa | UBERON:0002469 | 39.84 | silver quality |
| zone of skin | UBERON:0000014 | 38.57 | silver quality |
| bone marrow cell | CL:0002092 | 38.32 | gold quality |
| prostate gland | UBERON:0002367 | 37.64 | gold quality |
| granulocyte | CL:0000094 | 37.57 | gold quality |
| ganglionic eminence | UBERON:0004023 | 37.56 | silver quality |
| upper lobe of left lung | UBERON:0008952 | 37.28 | silver quality |
| urinary bladder | UBERON:0001255 | 37.11 | gold quality |
| skin of leg | UBERON:0001511 | 37.09 | silver quality |
| ectocervix | UBERON:0012249 | 36.57 | gold quality |
| pancreas | UBERON:0001264 | 36.49 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 36.02 | gold quality |
| placenta | UBERON:0001987 | 35.95 | silver quality |
| kidney | UBERON:0002113 | 35.77 | silver quality |
| lung | UBERON:0002048 | 35.74 | silver quality |
| superior frontal gyrus | UBERON:0002661 | 35.25 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 35.16 | gold quality |
| uterine cervix | UBERON:0000002 | 34.62 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.82 |
Regulation
Is transcription factor: no
Cross-species orthologs
20 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ENSDARG00000087805 | |
| mus_musculus | Cldn34c4 | ENSMUSG00000043569 |
| mus_musculus | Cldn34b2 | ENSMUSG00000057402 |
| mus_musculus | Cldn34b3 | ENSMUSG00000071738 |
| mus_musculus | Cldn34b1 | ENSMUSG00000072100 |
| mus_musculus | Cldn34b4 | ENSMUSG00000073085 |
| mus_musculus | Cldn34c1 | ENSMUSG00000079450 |
| mus_musculus | Cldn34d | ENSMUSG00000079525 |
| mus_musculus | Cldn34a | ENSMUSG00000091863 |
| mus_musculus | Cldn34c2 | ENSMUSG00000095474 |
| mus_musculus | Cldn34c6 | ENSMUSG00000118415 |
| mus_musculus | Cldn34c3 | ENSMUSG00000118430 |
| mus_musculus | Cldn34c5 | ENSMUSG00000118483 |
| rattus_norvegicus | Cldn34a | ENSRNOG00000024350 |
| rattus_norvegicus | Cldn34e | ENSRNOG00000026351 |
| rattus_norvegicus | Cldn34b4 | ENSRNOG00000029158 |
| rattus_norvegicus | Cldn34c4 | ENSRNOG00000031956 |
| rattus_norvegicus | Cldn34d | ENSRNOG00000043402 |
| rattus_norvegicus | Cldn34b | ENSRNOG00000065503 |
| rattus_norvegicus | Cldn34b3 | ENSRNOG00000071107 |
Paralogs (22): CLDN11 (ENSG00000013297), CLDN18 (ENSG00000066405), CLDN15 (ENSG00000106404), CLDN16 (ENSG00000113946), CLDN10 (ENSG00000134873), CLDN17 (ENSG00000156282), CLDN8 (ENSG00000156284), CLDN14 (ENSG00000159261), CLDN1 (ENSG00000163347), CLDN19 (ENSG00000164007), CLDN3 (ENSG00000165215), CLDN2 (ENSG00000165376), CLDN20 (ENSG00000171217), CLDN22 (ENSG00000177300), CLDN7 (ENSG00000181885), CLDN5 (ENSG00000184113), CLDN6 (ENSG00000184697), CLDN24 (ENSG00000185758), CLDN4 (ENSG00000189143), CLDN9 (ENSG00000213937), CLDN25 (ENSG00000228607), CLDN23 (ENSG00000253958)
Protein
Protein identifiers
Claudin-34 — H7C241 (reviewed: H7C241)
All UniProt accessions (1): H7C241
UniProt curated annotations — full annotation on UniProt →
Function. Plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity.
Subunit / interactions. Can form homo- and heteropolymers with other CLDN.
Subcellular location. Cell junction. Tight junction. Cell membrane.
Similarity. Belongs to the claudin family.
RefSeq proteins (1): NP_001182010* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR006187 | Claudin | Family |
UniProt features (10 total): topological domain 5, transmembrane region 4, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-H7C241-F1 | 86.14 | 0.60 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 11 (showing top):
GOCC_CELL_CELL_JUNCTION, GOCC_ANCHORING_JUNCTION, GOMF_STRUCTURAL_MOLECULE_ACTIVITY, chrXp22, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A, LEE_BMP2_TARGETS_UP, GOCC_TIGHT_JUNCTION, BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP, GLI1_TARGET_GENES, GOCC_APICAL_JUNCTION_COMPLEX, KEGG_MEDICUS_REFERENCE_TIGHT_JUNCTION_ACTIN_SIGNALING_PATHWAY
GO Biological Process (2): cell adhesion (GO:0007155), bicellular tight junction assembly (GO:0070830)
GO Molecular Function (1): structural molecule activity (GO:0005198)
GO Cellular Component (4): plasma membrane (GO:0005886), bicellular tight junction (GO:0005923), membrane (GO:0016020), anchoring junction (GO:0070161)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular process | 1 |
| apical junction assembly | 1 |
| tight junction assembly | 1 |
| molecular_function | 1 |
| membrane | 1 |
| cell periphery | 1 |
| apical junction complex | 1 |
| tight junction | 1 |
| cellular anatomical structure | 1 |
| cell junction | 1 |
Protein interactions and networks
STRING
92 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CLDN34 | CLDN24 | A6NM45 | 663 |
| CLDN34 | CLDN25 | C9JDP6 | 582 |
| CLDN34 | CLDN15 | P56746 | 520 |
| CLDN34 | CLDN17 | P56750 | 453 |
| CLDN34 | CLDN22 | Q8N7P3 | 446 |
| CLDN34 | CLDN18 | P56856 | 413 |
| CLDN34 | CLDN23 | Q96B33 | 376 |
| CLDN34 | CLDN9 | O95484 | 358 |
| CLDN34 | CLDN12 | P56749 | 323 |
| CLDN34 | CLDN16 | Q9Y5I7 | 321 |
| CLDN34 | RGS1 | Q08116 | 304 |
| CLDN34 | CLDN8 | P56748 | 304 |
| CLDN34 | CLDN6 | P56747 | 302 |
| CLDN34 | CLDN11 | O75508 | 296 |
| CLDN34 | CLDN5 | O00501 | 294 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A6NFC5, A6NM45, A8MUP6, B1AQL3, C3VMW3, C9JDP6, D3Z7H4, D3ZK93, H7C241, O75204, O88552, P0DP42, P56750, P57739, Q16617, Q2KIY2, Q2KJ11, Q32KQ5, Q3SZT1, Q3UUA0, Q497B3, Q4V922, Q5CZV0, Q5M962, Q5R9K1, Q6AYL2, Q6GV28, Q6ICI0, Q6UXU4, Q765P1, Q7T392, Q7YQI4, Q7Z7N9, Q8BGP5, Q8BXA6, Q8C6V3, Q8N7P3, Q8NHS1, Q8VHW1, Q8WXS4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
28 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 24 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
345 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:9967956:A:G | acceptor_gain | 0.8100 |
| X:9967667:A:T | donor_gain | 0.8000 |
| X:9967579:A:G | donor_gain | 0.7400 |
| X:9967665:G:GT | donor_gain | 0.7400 |
| X:9967475:A:T | donor_gain | 0.7000 |
| X:9967577:C:A | acceptor_gain | 0.6900 |
| X:9967585:C:G | donor_gain | 0.6900 |
| X:9967955:A:AG | acceptor_gain | 0.6700 |
| X:9967877:G:GT | donor_gain | 0.6600 |
| X:9967463:ATATG:A | donor_loss | 0.6500 |
| X:9967464:TATG:T | donor_loss | 0.6500 |
| X:9967465:ATG:A | donor_loss | 0.6500 |
| X:9967466:TGGT:T | donor_loss | 0.6500 |
| X:9967467:GGTAC:G | donor_loss | 0.6500 |
| X:9967468:G:C | donor_loss | 0.6500 |
| X:9967469:T:A | donor_loss | 0.6500 |
| X:9967666:G:GT | donor_gain | 0.6400 |
| X:9967954:C:G | acceptor_gain | 0.6300 |
| X:9967468:G:GG | donor_gain | 0.6200 |
| X:9967419:G:GT | donor_gain | 0.6100 |
| X:9967470:A:C | donor_loss | 0.6100 |
| X:9967592:G:GT | donor_gain | 0.6100 |
| X:9967666:G:T | donor_gain | 0.6100 |
| X:9967958:T:G | acceptor_gain | 0.6100 |
| X:9967718:G:GT | donor_gain | 0.6000 |
| X:9967680:T:G | donor_gain | 0.5900 |
| X:9967619:AT:A | acceptor_gain | 0.5800 |
| X:9967656:G:GT | donor_gain | 0.5800 |
| X:9967459:GCGAA:G | donor_gain | 0.5700 |
| X:9967526:G:GG | donor_gain | 0.5700 |
AlphaMissense
1405 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:9967835:T:C | F160L | 0.875 |
| X:9967837:C:A | F160L | 0.875 |
| X:9967837:C:G | F160L | 0.875 |
| X:9967457:T:A | W34R | 0.854 |
| X:9967457:T:C | W34R | 0.854 |
| X:9967520:T:C | F55L | 0.844 |
| X:9967522:T:A | F55L | 0.844 |
| X:9967522:T:G | F55L | 0.844 |
| X:9967459:G:C | W34C | 0.833 |
| X:9967459:G:T | W34C | 0.833 |
| X:9967598:T:C | F81L | 0.814 |
| X:9967600:T:A | F81L | 0.814 |
| X:9967600:T:G | F81L | 0.814 |
| X:9967421:T:A | W22R | 0.803 |
| X:9967421:T:C | W22R | 0.803 |
| X:9967646:A:C | S97R | 0.769 |
| X:9967648:C:A | S97R | 0.769 |
| X:9967648:C:G | S97R | 0.769 |
| X:9967736:T:C | F127L | 0.765 |
| X:9967738:C:A | F127L | 0.765 |
| X:9967738:C:G | F127L | 0.765 |
| X:9967876:G:C | Q173H | 0.764 |
| X:9967876:G:T | Q173H | 0.764 |
| X:9967466:T:A | W37R | 0.754 |
| X:9967466:T:C | W37R | 0.754 |
| X:9967461:G:C | R35P | 0.751 |
| X:9967400:T:C | F15L | 0.746 |
| X:9967402:C:A | F15L | 0.746 |
| X:9967402:C:G | F15L | 0.746 |
| X:9967568:T:C | F71L | 0.712 |
dbSNP variants (sampled 300 via entrez): RS1001418516 (X:9968398 A>C), RS1002662249 (X:9965415 C>G), RS1003616920 (X:9967607 T>C,G), RS1004163797 (X:9965379 A>T), RS1004870941 (X:9966948 A>G), RS1005149743 (X:9967409 A>G), RS1005562414 (X:9967302 T>TC), RS1006207881 (X:9968624 A>C), RS1009068533 (X:9965894 G>A), RS1010009787 (X:9968351 C>T), RS1010906361 (X:9966294 C>T), RS1012476641 (X:9967445 G>A), RS1014369076 (X:9965865 A>C,G), RS1015242721 (X:9967413 C>T), RS1015296548 (X:9967065 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB variants
1 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs5934731 | CLDN34 | 0.00 | 0 |
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.